Search Results 491-500 of 17047 for monoclonal antibody

  1. Thyroid Cancer Clinical Trials - Mayo Clinic Research

    Monoclonal antibodies, such as pembrolizumab, may interfere with the ability of tumor cells to grow and spread. Drugs used in chemotherapy, such as ...

  2. Publications - Teresa A. Seville, M.D. - Mayo Clinic

    ... Monoclonal Antibodies. Open Forum Infect Dis. 2022 Jul; 9 (7):ofac204 ... Monoclonal Antibody Therapy for COVID-19 in Solid Organ Transplant Recipients.

  3. MAYO CLINIC 2021 FACT SHEET Feb. 28, 2022

    Mayo staff administered more than 19,000 monoclonal antibody infusions for patients with COVID-. 19. • Mayo Clinic Laboratories, which serves health care ...

  4. Erlotinib with or without Bevacizumab in Treating Patients with Stage IV Non-Small Cell Lung Cancer with EGFR Mutations - Mayo Clinic

    Monoclonal antibodies, such as bevacizumab, can block tumor growth in different ways. Bevacizumab blocks the ability of tumors to grow new blood vessels and ...

  5. Clinical trials - Oncology (Medical)

    Monoclonal antibodies, such as rituximab, may block cancer growth in different ways by targeting certain cells. Romidepsin and lenalidomide may stop the ...

  6. Mike M. Bierle, M.D. - Doctors and Medical Staff - Mayo Clinic

    Leadership CommitteeCOVID-19 Monoclonal Antibody Treatment (MATRx) Team. 2021 - present. Committee MemberMultidisciplinary Approach Guiding Post-COVID ...

  7. Epidemiology of Monoclonal B-Cell Lymphocytosis Study - B-Cell Lymphoproliferative Disorders - Mayo Clinic Research

    The Slager B-Cell Lymphoproliferative Disorders Lab at Mayo Clinic is studying connections between monoclonal B-cell lymphocytosis and blood and lymph node ...

  8. Monoclonal gammopathy of undetermined significance (MGUS) - Diagnosis and treatment - Mayo Clinic

    More blood tests. These can help rule out other causes of higher protein levels. And they can check for kidney damage. Urine tests. Urine samples taken over 24 ...

  9. Azacitidine With or Without Nivolumab or Midostaurin, or Decitabine and Cytarabine Alone in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome - Mayo Clinic

    Monoclonal antibodies, such as nivolumab, may interfere with the ability of cancer cells to grow and spread. Midostaurin may stop the growth of cancer cells ...

  10. Clinical trials - Oncology (Medical)

    Monoclonal antibodies, such as inotuzumab ozogamicin, may block cancer growth in different ways by targeting certain cells. Drugs used in chemotherapy work ...